This requires Flash to play. Click here to download.

The information on this site is intended for health care professionals
in the United States and is not intended for the general public.

I AM A HEALTHCARE PROFESSIONAL I AM NOT A HEALTHCARE PROFESSIONAL
Zolinza® [vorinostat] capsules Reactivate Expression
Patient Product Information

Internet resources

Recent advances in molecular biology have contributed significantly to our understanding of cancer genetics and tumor formation. As we continue to study normal and aberrant cell physiology, therapeutic agents targeted specifically at cancer cells continue to attract vast amounts of investigational attention. The following materials and Web links share information about emerging oncology targets to further improve patient treatment.

Oncology Web links

The following Web sites may provide additional information to help you treat and support your patients.

Back to top

Dermatology Web links

The following Web sites may provide additional information to help you treat and support your patients.

Back to top

Clinical trial links

Back to top

Educational and emotional support

Back to top


ZOLINZA is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

This site is intended only for health care professionals of the United States, its territories, and Puerto Rico.

20951007(6)-07/09-ZOL
For general information and other services for physicians
MERCK MEDICUSMERCK SOURCEMERCKServices
MerckMedicus, MerckSource, and MerckServices are trademarks of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.